TSC2 and lymphangioleiomyomatosis: Tissue remodeling as a consequence of deregulated TSC2 expression and/or function in the lung may include abnormal vasculature, loss of epithelial structure, smooth muscle cell accumulation, and formation of nonmalignant tumors as described in tuberous sclerosis and lymphangioleiomyomatosis (LAM) (15–17).